Current Liabilities Veränderung
Alnylam Pharmaceuticals ALNY:US $ 657.68M 51.72M
Amgen AMGN:US $ 12618M 268M
Avrobio Inc AVRO:US $ 12.78M 4.34M
Bayer BAYN:GR € 33643M 2624M
Biogen BIIB:US $ 5018M 1071.4M
Biomarin Pharmaceutical BMRN:US $ 464.73M 25.69M
Bluebird Bio BLUE:US $ 148.86M 5.97M
Gilead Sciences GILD:US $ 9220M 662M
GlaxoSmithKline GSK:LN 3783500M 1355700M
Intercept Pharmaceuticals ICPT:US $ 151.43M 0.39M
IONIS PHARMACEUT IONS:US $ 267.81M 39.36M
Karyopharm Therapeutics KPTI:US $ 62.54M 3.8M
Novartis NOVN:VX SF 27646M 2161M
Omeros OMER:US $ 38.5M 3.44M
Regulus Therapeutics RGLS:US $ 5.83M 1.13M
Sangamo Biosciences SGMO:US $ 119.99M 1.46M
Sarepta Therapeutics SRPT:US $ 545.57M 90.6M
Ultragenyx Pharmaceutical RARE:US $ 220.64M 53.4M
Vertex Pharmaceuticals VRTX:US $ 2556.2M 376M
Ziopharm Oncology ZIOP:US $ 26.78M 5.54M



Sangamo BioSciences Aktuelle Verpflichtungen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2022.